Uganda had allowed the use of three investigational treatments for Ebola virus infection from Mapp Biopharmaceutical, Gilead Sciences and Regeneron Pharmaceuticals. In the Democratic Republic of Congo, 2,087 cases have now been confirmed and another 322 suspected cases are being evaluated.
Investigative Ebola treatments cleared for shipment to Uganda
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.